Latest Research & Development Jobs

Medical Director-Oncology Clinical Development - GI

This role involves serving as the physician lead within an oncology clinical development team, providing medical expertise in study design, safety oversight, and data interpretation for gastrointestinal (GI) cancer trials. The Medical Director ensures patient safety and clinical integrity across clinical studies, collaborates with cross-functional teams and external experts, and contributes to regulatory submissions and scientific communications. The position supports GSK’s mission to advance innovative cancer treatments grounded in disease biology and real-world impact.

GSK £222,750 – £371,250 pa

Medical Director-Oncology Clinical Development - GI

This role involves leading medical monitoring and safety oversight for gastrointestinal (GI) oncology clinical trials within GSK’s global development programme. The Medical Director provides physician-level expertise in study design, data interpretation, and regulatory engagement, ensuring patient safety and clinical integrity across phases I–III. Working within a cross-functional matrix team, the role integrates medical insight into clinical strategy and collaborates with external experts and investigators to advance innovative cancer therapies.

GSK

Hybrid Permanent

Senior Medical Director, Oncology Clinical Development - GU

This role involves leading clinical development activities for GSK’s oncology portfolio, with a focus on genitourinary (GU) cancers. The Senior Medical Director will design and execute Phase 1-3 clinical trials, provide medical oversight, interpret clinical data, and engage with external experts and regulatory authorities. The position requires strong leadership in a matrixed environment and deep expertise in oncology drug development.

GSK Stevenage, United Kingdom US$284,250 – US$473,750 pa

Hybrid Permanent

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development for oncology assets, focusing on genitourinary (GU) cancers, with responsibility for designing and executing global Phase 1-3 trials. Provides medical oversight, ensures scientific integrity, and collaborates with internal teams and external experts to support regulatory submissions and product lifecycle management. Engages in strategic initiatives and represents GSK in medical forums.

GSK United Kingdom US$284,250 – US$473,750 pa

Hybrid Permanent

Senior Medical Director, Oncology Clinical Development - GU

Lead clinical development for oncology assets, focusing on genitourinary (GU) cancers, with responsibility for designing and executing global Phase 1-3 trials. Drive medical strategy, collaborate with key external experts, and ensure scientific integrity across clinical programs. Work within a matrix environment to support regulatory filings and lifecycle management of innovative therapies.

GSK £284,250 – £473,750 pa

Hybrid Permanent

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development for oncology assets, focusing on genitourinary (GU) cancers. Responsible for designing and executing phase 1-3 trials, ensuring scientific integrity, regulatory compliance, and collaboration with internal and external experts. Works within a global matrix to advance GSK’s innovative oncology pipeline from development through market launch.

GSK US$284,250 – US$473,750 pa

Hybrid Permanent

Senior Medical Director, Oncology Clinical Development - GU

This role involves leading clinical development for oncology assets, specifically in genitourinary (GU) cancers, within a global matrix environment. The Senior Medical Director will design and execute phase 1–3 clinical trials, provide medical oversight, interpret study data, and engage with external experts and regulatory authorities. The position plays a key strategic role in advancing GSK’s oncology pipeline from development through regulatory approval and lifecycle management.

GSK US$284,250 – US$473,750 pa

On-site Permanent

Head, Oncology Clinical Development - ADCs

Leads end-to-end clinical development of an antibody-drug conjugate (ADC) oncology asset across multiple tumor types, from first-in-human through registrational trials and launch. Responsible for shaping clinical strategy, overseeing global trials, engaging with regulatory authorities, and integrating translational research and innovative approaches like AI/ML and real-world evidence. Acts as senior clinical representative in governance forums and external scientific engagements.

GSK Stevenage, United Kingdom US$242,250 – US$403,750 pa

Head, Oncology Clinical Development - ADCs

Lead the clinical development strategy for antibody-drug conjugates (ADCs) across multiple tumor types, from early-phase through registrational trials and market launch. Drive integrated clinical and translational research, represent the asset at key governance forums, and shape portfolio-level decision-making in oncology. Work across global cross-functional teams to advance innovative therapies within a matrixed biopharma environment.

GSK United States £242,250 – £403,750 pa

Head, Oncology Clinical Development - ADCs

Leads the end-to-end clinical development of an antibody-drug conjugate (ADC) oncology asset across multiple tumor types, from first-in-human through registrational trials and launch readiness. Responsible for shaping clinical strategy, overseeing global trials, engaging with regulatory authorities, and leading cross-functional teams in a matrixed environment. Involves governance leadership, scientific advisory boards, and integration of innovative approaches such as AI/ML and real-world evidence to accelerate development.

GSK US$242,250 – US$403,750 pa

Head, Oncology Clinical Development - ADCs

Leads the clinical development strategy for antibody-drug conjugates (ADCs) in oncology, spanning early- to late-phase trials across multiple tumor types. Responsible for end-to-end asset development, including regulatory approval and launch readiness, with a focus on scientific rigor, innovation in trial design, and cross-functional collaboration. Engages with global health authorities, governance bodies, and external experts to shape clinical and translational strategies.

GSK US$242,250 – US$403,750 pa

Head, Oncology Clinical Development - ADCs

Leads end-to-end clinical development of an antibody-drug conjugate (ADC) oncology asset across multiple tumor types, from first-in-human through registrational trials and market launch. Drives integrated clinical strategy, translational research, regulatory submissions, and cross-functional collaboration across global teams. Engages with governance bodies, scientific advisory boards, and external experts to shape development and competitive positioning.

GSK US$242,250 – US$403,750 pa

Senior Medical Director, Oncology Clinical Development - GU

The Senior Medical Director, Oncology Clinical Development - GU will lead clinical research activities for GSK’s oncology portfolio, focusing on GU cancers. Responsibilities include developing and executing clinical trials, collaborating with internal and external experts, and ensuring regulatory compliance. The role requires significant experience in GU oncology drug development and a strong medical background.

GSK

VP, Medicine Development Leader - Specialty Product Development

This role leads the global development of a medicine from clinical proof of concept to first-market approval, serving as the single point of accountability within GSK's matrixed R&D environment. The VP Medicine Development Leader will build and lead a cross-functional team, define strategic development plans, and ensure alignment with regulatory, commercial, and manufacturing stakeholders. The position emphasizes evidence-based decision-making, lifecycle planning, and patient-focused development across multiple indications.

GSK Stevenage, United Kingdom £242,250 – £403,750 pa

VP, Medicine Development Leader - Specialty Product Development

Lead the global development of a specialty medicine from clinical proof of concept to first-market approval, serving as the single point of accountability across a matrixed, cross-functional team. Define strategic vision, oversee clinical and regulatory planning, and make evidence-based go/no-go decisions. Engage with regulators, senior leadership, and external stakeholders to advance patient-focused drug development within GSK’s R&D strategy.

GSK United States £242,250 – £403,750 pa